News Roundup: April 10 - April 14
Your weekly roundup of the latest news from Drug Topics®.
Menopause May Increase Risk of Glaucoma but Estrogen Therapy Could Help, Study Finds
A recent study showed a link between menopause and increased glaucoma risk, with estrogen-based treatment being a possible solution.
Oncology Pharmacists Are Crucial in Skin Cancer Management
From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.
A Biosimilar Wave Looms Large Over US Biologics Market
As more adalimumab biosimilars are poised to enter the market, manufacturers, payers, and patient advocates are preparing to navigate potentially turbulent waters.
What Pharmacists Need to Know About Point-of-Care Testing for STIs
Pharmacists need a depth and breadth of knowledge to get the most out of point-of-care testing for sexually transmitted infections.
Age, Food Security, And Financial Situation All Common Factors in OUD Cases
A new study from JAPHA explores the link between OUD and social factors.
Hundreds Of Pharma Executives Sign Open Letter Condemning Mifepristone Ruling
Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
